A Trial Investigating the Safety, Tolerability, Availability and Distribution in the Body of Once-weekly Long-acting Growth Hormone (Somapacitan) Compared to Once Daily Norditropin NordiFlex® in Adults With Growth Hormone Deficiency

Clinical trial NCT01706783 · COMPLETED

Trial details

NCT number: NCT01706783
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Growth Hormone Disorder Adult Growth Hormone Deficiency

Start date: 2012-10-12
Primary completion: 2013-11-18
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.